CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic Material
CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic Material
Recruiting · NCT07276711 · Registry updated 2026-08-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic Material | Ventricular Outflow Obstruction, aortic valve disorder, aortic valve stenosis, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, heart disorder, heart valve disorder, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Not applicable | 2026-08-26 | NCT07276711 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bright Research Partners | 10 |
| EmStop Inc | 1 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Los Robles Regional Medical Center | Thousand Oaks | United States | 15 |
| Methodist Research Institute | San Antonio | United States | 1 |
| Mission Health | Asheville | United States | 5 |
| Monument Health Heart and Vascular Institute | Rapid City | United States | 1 |
| Morton Plant Hospital | BayCare Health | Clearwater | United States | 1 |
| Ochsner Medical Center | New Orleans | United States | 26 |
| University of Michigan Health | Michigan Medicine | Ann Arbor | United States | 1 |